HNF-1B has been demonstrated to be associated with the risk of several tumors, including HCC, pancreatic carcinoma, renal cancer, ovarian cancer, endometrial cancer, and prostate cancer4, 18, 19, 20, 21. Here, HNF1B is linked to exocrine pancreatic carcinoma.